A method to address discrepancies between predicted biological age and actual chronological age has been validated as a biomarker in predicting OS.

An artificial intelligence-based imaging analysis could serve as an aid in surgical planning for patients with kidney tumors.

After nephron-sparing treatment for RCC, patients with local recurrence had a higher mortality risk than patients without recurrence.

Current risk stratification models perform well in assessing recurrence risk in patients with non-clear cell renal cell carcinoma, researchers report.

An AI-based model for analyzing images appeared better able to predict ccRCC from CT-based images than a tumor size-based model was.

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

These findings support the potential of AI-driven histopathological analysis as a biomarker in melanoma,” study researchers wrote.

The researchers noted that the findings support the existing literature and suggest a connection between severe sunburns and CSCC that is similar to what is seen with basal cell carcinoma.

Cabozantinib has shown efficacy in the treatment of renal cell carcinoma with non-locally pretreated brain metastases, researchers report.

Researchers assessed whether combination mosunetuzumab and polatuzumab vedotin would reduce the risk of disease progression or death in patients with LBCL.

Oncocytomas, oncocytic neoplasms of low malignant potential, and lower-stage chromophobe RCC do not recur with prolonged follow-up.

In patients with renal cell carcinoma, greater abdominal adiposity and lower skeletal mass are associated with aggressive pathology.